Focal liver lesion detection and characterization: Comparison of non-contrast enhanced and SPIO-enhanced diffusion-weighted single-shot spin echo echo planar and turbo spin echo T2-weighted imaging

European Journal of Radiology

Volumn 72, Issue 3, 2009, Pages 432-439

  Coenegrachts, Kenneth ^a   Matos, Celso ^b   ter Beek, Léon ^c   Metens, Thierry ^b   Haspeslagh, Marc ^d   Bipat, Shandra ^e   Stoker, Jaap ^e   Rigauts, Hans ^a  

^a Department of Radiology ^*  (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c PHILIPS HEALTHCARE   (United States)

^d Hospital Administration and Statistics   (Belgium)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Diffusion magnetic resonance imaging; EPI; Ferucarbotran; Liver

Indexed keywords

B VALUE; CONSPICUITY; CONTRAST-ENHANCED; DIFFUSION MAGNETIC RESONANCE IMAGING; ECHO PLANAR IMAGING; ENHANCED DIFFUSION; EXACT TESTS; FOCAL LIVER LESIONS; LESION DETECTION; LIVER METASTASIS; MALIGNANT LESION; RANK-ORDER STATISTICS; REFERENCE STANDARD; SINGLE-SHOT; SPIN ECHO; SUPERPARAMAGNETIC IRON OXIDES; T2-WEIGHTED IMAGING; TURBO SPIN ECHOS;

DIFFUSION; IMAGE QUALITY; IRON OXIDES; LIVER; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; SPIN DYNAMICS; SPIN POLARIZATION; SUPERPARAMAGNETISM;

SPONTANEOUS EMISSION;

SUPERPARAMAGNETIC IRON OXIDE;

ADULT; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COLORECTAL LIVER METASTASIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE QUALITY; INTERMETHOD COMPARISON; LIVER INJURY; LIVER METASTASIS; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; SINGLE SHOT SPIN ECHO ECHO PLANAR IMAGING; TUMOR BIOPSY; TURBO SPIN ECHO T2 WEIGHTED IMAGING;

COLORECTAL NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; ECHO-PLANAR IMAGING; FEMALE; FERROSOFERRIC OXIDE; HUMANS; IMAGE ENHANCEMENT; LIVER NEOPLASMS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 70449633653     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2008.09.005     Document Type: Article

References (18)

1. Ward J. New MR techniques for the detection of liver metastases. Cancer Imaging 6 (2006) 33-42
2. Kim Y., Lee J., Kim C., Chung G., Kim C., and Kim I. Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol 15 (2005) 220-228
3. Kim M., Kim J., Lim J., et al. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging. JMRI 20 (2004) 612-621
4. Nasu K., Kuroki Y., Nawano S., et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 239 (2006) 122-130
5. 2w turbo spin echo techniques. Br J Radiol 80 (2007) 524-531
6. Bruegel M., Holzapfel K., Gaa J., et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 18 (2008) 477-485
7. Semelka R., Brown E., Ascher S., et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 192 (1994) 401-406
8. Denys A., Arrive L., Servois V., Dubray B., Najmark D., Sibert A., and Menu Y. Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology 193 (1994) 665-669
9. Paley M., Mergo P., Torres G., et al. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging. Am J Roentgenol 175 (2000) 159-163
10. Grandin C., Van Beers B., Robert A., et al. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. J Comput Assist Tomogr 19 (1995) 412-418
11. Seneterre E., Taourel P., Bouvier Y., et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200 (1996) 785-792
12. Ward J., Naik K., Guthrie J., Wilson D., and Robinson P. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 210 (1999) 459-466
13. Lim J., Choi D., Cho S., et al. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 220 (2001) 669-676
14. Bross I.D.J. How to use RIDIT analysis. Biometrics 14 (1958) 18-38
15. Kiryu S., Watanabe M., Kabasawa H., Akahane M., Aoki S., and Ohtomo K. Evaluation of super paramagnetic iron oxide-enhanced diffusion-weighted PROPELLER T2-fast spin echo magnetic resonance imaging: Preliminary experience. J Comput Assist Tomogr 30 (2006) 197-200
16. Mori K., Takahashi N., Hiratsuka M., et al. Detection of hepatic metastases using ferucarbotran-enhanced MR imaging: Feasibility and diagnostic accuracy of three-dimensional sensitivity-encoding water-excitation multishot echo-planar sequence (3D-SWEEP). JMRI 24 (2006) 1110-1116
17. Naganawa S., Sato C., Nakamura T., et al. Diffusion-weighted images of the liver: comparison of tumor detection before and after contrast enhancement with superparamagnetic iron oxide. JMRI 21 (2005) 836-840
18. Coenegrachts K., Orlent H., ter Beek L., et al. Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI. JMRI 27 (2008) 117-124